FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904694536> ?p ?o ?g. }

• W2904694536 endingPage "1252.e1" @default.
• W2904694536 startingPage "1246" @default.
• W2904694536 abstract "BackgroundThe impact of atopic dermatitis (AD) on health-related quality of life and health utility in the US adult population is not well established.ObjectiveTo determine the health utilities and quality-adjusted life-years (QALYs) lost in adults with AD versus without AD in the US population.MethodsA cross-sectional, population-based study of 3495 adults was performed. AD was determined using modified UK diagnostic criteria for AD. AD severity was assessed using self-reported global AD severity, the Patient-Oriented Eczema Measure, the Patient-Oriented Scoring AD, and the Patient-Oriented Scoring AD itch and sleep. Six-dimensional health state short form (SF-6D) health utility scores and total QALY loss were assessed.ResultsThe mean SF-6D score was lower in adults with AD compared with healthy adults (0.69 [95% CI, 0.68-0.70] versus 0.79 [95% CI, 0.77-0.79]). In particular, those with moderate-to-severe AD (mean, 0.53-0.66) had similar or lower SF-6D scores compared with those with all other self-reported disorders examined, except autoimmune disorders. Adults with AD and atopic comorbidities had significantly lower SF-6D scores compared with those without atopic comorbidities. Among the 7 disorders examined, AD was associated with higher total QALY loss than autoimmune disorders, diabetes, food allergy, and heart disease in both males and females. The largest QALY loss was for moderate AD in females and mild AD in males.ConclusionsModerate-to-severe AD is associated with significant decrements of health utility in the US population. These data illustrate the heavy societal burden of moderate and severe AD and provide important insight for prioritization of resource allocation and cost-effectiveness research. The impact of atopic dermatitis (AD) on health-related quality of life and health utility in the US adult population is not well established. To determine the health utilities and quality-adjusted life-years (QALYs) lost in adults with AD versus without AD in the US population. A cross-sectional, population-based study of 3495 adults was performed. AD was determined using modified UK diagnostic criteria for AD. AD severity was assessed using self-reported global AD severity, the Patient-Oriented Eczema Measure, the Patient-Oriented Scoring AD, and the Patient-Oriented Scoring AD itch and sleep. Six-dimensional health state short form (SF-6D) health utility scores and total QALY loss were assessed. The mean SF-6D score was lower in adults with AD compared with healthy adults (0.69 [95% CI, 0.68-0.70] versus 0.79 [95% CI, 0.77-0.79]). In particular, those with moderate-to-severe AD (mean, 0.53-0.66) had similar or lower SF-6D scores compared with those with all other self-reported disorders examined, except autoimmune disorders. Adults with AD and atopic comorbidities had significantly lower SF-6D scores compared with those without atopic comorbidities. Among the 7 disorders examined, AD was associated with higher total QALY loss than autoimmune disorders, diabetes, food allergy, and heart disease in both males and females. The largest QALY loss was for moderate AD in females and mild AD in males. Moderate-to-severe AD is associated with significant decrements of health utility in the US population. These data illustrate the heavy societal burden of moderate and severe AD and provide important insight for prioritization of resource allocation and cost-effectiveness research." @default.
• W2904694536 created "2018-12-22" @default.
• W2904694536 creator A5007184966 @default.
• W2904694536 creator A5011739266 @default.
• W2904694536 creator A5014647604 @default.
• W2904694536 creator A5015905197 @default.
• W2904694536 creator A5033795032 @default.
• W2904694536 creator A5043556111 @default.
• W2904694536 creator A5055081212 @default.
• W2904694536 creator A5057661348 @default.
• W2904694536 creator A5069889904 @default.
• W2904694536 date "2019-04-01" @default.
• W2904694536 modified "2023-09-25" @default.
• W2904694536 title "Health Utility Scores of Atopic Dermatitis in US Adults" @default.
• W2904694536 cites W1574564122 @default.
• W2904694536 cites W1653624018 @default.
• W2904694536 cites W1700981343 @default.
• W2904694536 cites W1982061770 @default.
• W2904694536 cites W1991908216 @default.
• W2904694536 cites W1995445363 @default.
• W2904694536 cites W2043469120 @default.
• W2904694536 cites W2052095388 @default.
• W2904694536 cites W2053134332 @default.
• W2904694536 cites W2053248776 @default.
• W2904694536 cites W2073210383 @default.
• W2904694536 cites W2090735611 @default.
• W2904694536 cites W2092052931 @default.
• W2904694536 cites W2094896035 @default.
• W2904694536 cites W2096991001 @default.
• W2904694536 cites W2102985737 @default.
• W2904694536 cites W2104004846 @default.
• W2904694536 cites W2104263215 @default.
• W2904694536 cites W2137866495 @default.
• W2904694536 cites W2142290318 @default.
• W2904694536 cites W2162533344 @default.
• W2904694536 cites W2172151487 @default.
• W2904694536 cites W2211830044 @default.
• W2904694536 cites W2276335262 @default.
• W2904694536 cites W2305795634 @default.
• W2904694536 cites W2340697617 @default.
• W2904694536 cites W2463705312 @default.
• W2904694536 cites W2470212554 @default.
• W2904694536 cites W2470653389 @default.
• W2904694536 cites W2487179012 @default.
• W2904694536 cites W2510220995 @default.
• W2904694536 cites W2516859771 @default.
• W2904694536 cites W2518331667 @default.
• W2904694536 cites W2524051065 @default.
• W2904694536 cites W2531261466 @default.
• W2904694536 cites W2538996231 @default.
• W2904694536 cites W2557191479 @default.
• W2904694536 cites W2755843354 @default.
• W2904694536 cites W2772411615 @default.
• W2904694536 cites W2883568898 @default.
• W2904694536 cites W2884232193 @default.
• W2904694536 cites W2885257319 @default.
• W2904694536 cites W2889552403 @default.
• W2904694536 cites W2899071879 @default.
• W2904694536 cites W3190527361 @default.
• W2904694536 cites W4246496850 @default.
• W2904694536 cites W882142775 @default.
• W2904694536 doi "https://doi.org/10.1016/j.jaip.2018.11.043" @default.
• W2904694536 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30537560" @default.
• W2904694536 hasPublicationYear "2019" @default.
• W2904694536 type Work @default.
• W2904694536 sameAs 2904694536 @default.
• W2904694536 citedByCount "42" @default.
• W2904694536 countsByYear W29046945362019 @default.
• W2904694536 countsByYear W29046945362020 @default.
• W2904694536 countsByYear W29046945362021 @default.
• W2904694536 countsByYear W29046945362022 @default.
• W2904694536 countsByYear W29046945362023 @default.
• W2904694536 crossrefType "journal-article" @default.
• W2904694536 hasAuthorship W2904694536A5007184966 @default.
• W2904694536 hasAuthorship W2904694536A5011739266 @default.
• W2904694536 hasAuthorship W2904694536A5014647604 @default.
• W2904694536 hasAuthorship W2904694536A5015905197 @default.
• W2904694536 hasAuthorship W2904694536A5033795032 @default.
• W2904694536 hasAuthorship W2904694536A5043556111 @default.
• W2904694536 hasAuthorship W2904694536A5055081212 @default.
• W2904694536 hasAuthorship W2904694536A5057661348 @default.
• W2904694536 hasAuthorship W2904694536A5069889904 @default.
• W2904694536 hasBestOaLocation W29046945361 @default.
• W2904694536 hasConcept C126322002 @default.
• W2904694536 hasConcept C134018914 @default.
• W2904694536 hasConcept C159110408 @default.
• W2904694536 hasConcept C187212893 @default.
• W2904694536 hasConcept C203014093 @default.
• W2904694536 hasConcept C205545832 @default.
• W2904694536 hasConcept C2778329239 @default.
• W2904694536 hasConcept C2779951463 @default.
• W2904694536 hasConcept C2908647359 @default.
• W2904694536 hasConcept C555293320 @default.
• W2904694536 hasConcept C71924100 @default.
• W2904694536 hasConcept C99454951 @default.
• W2904694536 hasConceptScore W2904694536C126322002 @default.
• W2904694536 hasConceptScore W2904694536C134018914 @default.
• W2904694536 hasConceptScore W2904694536C159110408 @default.

• next